Kellner, C., Günther, A., Humpe, A., Repp, R., Klausz, K., Derer, S., . . . Peipp, M. (2015). Enhancing natural killer cell-mediated lysis of lymphoma cells by combining therapeutic antibodies with CD20-specific immunoligands engaging NKG2D or NKp30. Oncoimmunology.
Chicago ZitierstilKellner, Christian, et al. "Enhancing Natural Killer Cell-mediated Lysis of Lymphoma Cells By Combining Therapeutic Antibodies With CD20-specific Immunoligands Engaging NKG2D or NKp30." Oncoimmunology 2015.
MLA ZitierstilKellner, Christian, et al. "Enhancing Natural Killer Cell-mediated Lysis of Lymphoma Cells By Combining Therapeutic Antibodies With CD20-specific Immunoligands Engaging NKG2D or NKp30." Oncoimmunology 2015.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.